| 304 |
TBX1 inhibition leading to congenital cardiac conotruncal anomalies |
Jinsoo Lee |
BY-SA |
1680: Inhibition, TBX1
|
1685: Anomalies, Congenital cardiac conotruncal
|
|
|
| 393 |
AOP for thyroid disorder caused by triphenyl phosphate via TRβ activation |
Fei Li |
BY-SA |
1158: Increased, Hepatic thyroid hormone uptake/transport
|
None
|
|
|
| 423 |
Toxicological mechanisms of hepatocyte apoptosis through the PARP1 dependent cell death pathway |
Fei Li |
BY-SA |
2 MIEs
|
1817: Apoptotic cell death
|
|
|
| 401 |
G protein-coupled estrogen receptor 1 (GPER) signal pathway in the lipid metabolism disrupting effects |
Fei Li |
BY-SA |
2029: protein-coupled estrogen receptor 1 (GPER) activation
|
1489: Increase, Steatohepatitis
|
|
|
| 408 |
Imbalance in redox homeostasis leading to structural damage to tissues |
Fei Li |
BY-SA |
None
|
None
|
|
|
| 531 |
VEGFR inhibition leading to Keratinocyte differentiation-associate Hand-foot skin reaction |
Hui Li |
BY-SA |
None
|
None
|
|
|
| 514 |
PLK1 Activation leading to hepatocyte apoptosis-associate liver injury via autophagy-mediated excessive COX6A1 degradation and impaired function of mitochondrial respiratory chain complex IV |
Hui Li |
BY-SA |
None
|
None
|
|
|
| 495 |
Androgen receptor activation leading to prostate cancer |
Jianxiang Li |
BY-SA |
25: Agonism, Androgen receptor
|
2135: Prostate cancer
|
|
|
| 463 |
The AOP framwork on silica nanopariticles induced hepatoxicity |
Tianyu Li |
BY-SA |
None
|
None
|
|
|
| 446 |
PM-related Adverse outcome pathway frameworks on various systems |
Tianyu Li |
BY-SA |
None
|
None
|
|
|
| 107 |
Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas in the mouse and the rat |
Kristin Lichti-Kaiser |
BY-SA |
715: Activation, Constitutive androstane receptor
|
719: Increase, hepatocellular adenomas and carcinomas
|
Under Review |
1.17 |
| 496 |
Androgen receptor agonism leading to reproduction dysfunction (in zebrafish) |
Hongling Liu |
BY-SA |
25: Agonism, Androgen receptor
|
442: Decreased, Population trajectory
|
|
|
| 549 |
Aromatase inhibition leads to reproductive toxicity (including growth and developmental toxicity) in adult female zebrafish |
Hongling Liu |
BY-SA |
36: Inhibition, Aromatase
|
3 AOs
|
|
|
| 149 |
Peptide Oxidation Leading to Hypertension |
Frazer Lowe |
BY-SA |
209: Peptide Oxidation
|
952: Hypertension
|
Under Development |
1.50 |
| 148 |
EGFR Activation Leading to Decreased Lung Function |
Karsta Luettich |
BY-SA |
941: Activation, EGFR
|
1250: Decrease, Lung function
|
Under Development |
1.51 |
| 411 |
Oxidative stress Leading to Decreased Lung Function |
Karsta Luettich |
BY-SA |
1392: Increase, Oxidative Stress
|
1250: Decrease, Lung function
|
|
|
| 425 |
Oxidative Stress Leading to Decreased Lung Function via Decreased FOXJ1 |
Karsta Luettich |
BY-SA |
1392: Increase, Oxidative Stress
|
1250: Decrease, Lung function
|
|
|
| 424 |
Oxidative stress Leading to Decreased Lung Function via CFTR dysfunction |
Karsta Luettich |
BY-SA |
1392: Increase, Oxidative Stress
|
1250: Decrease, Lung function
|
|
|
| 586 |
The increasing accumulation of HMGB1 in the nucleus causes cardiomyocyte death via HMGB1/HSPB1/CCN2 pathway |
Peihua Luo |
All rights reserved |
None
|
None
|
|
|
| 582 |
Inhibition of EphA2 phosphorylation leads to liver damage via the ERK/ MDM2/p53 axis |
Peihua Luo |
All rights reserved |
None
|
None
|
|
|
| 583 |
Vascular endothelial HER2 inhibition disrupts cardiomyocyte calcium homeostasis via EGFR/STAT3/PTX3 axis leading to cardiac contractile dysfunction |
Peihua Luo |
All rights reserved |
None
|
None
|
|
|
| 584 |
SQLE accumulation leads to hepatotoxicity via cholesterol/sphingolipid metabolic disturbance and lysosomal damage |
Peihua Luo |
All rights reserved |
None
|
None
|
|
|
| 585 |
AKT Inhibition blocks the autophagy flow through the PRKAA/AMPK pathway and leads to cardiotoxicity |
Peihua Luo |
All rights reserved |
None
|
None
|
|
|
| 532 |
Retinoic acid receptor agonism during cerebellar development leading to impaired locomotor function |
Diana Lupu |
Open for adoption |
2201: Agonism, Retinoic acid receptor
|
2231: Locomotor function. Impaired
|
|
|
| 533 |
Retinoic acid receptor antagonism during neurodevelopment leading to impaired learning and memory |
Diana Lupu |
Open for adoption |
2232: Antagonism, Retinoic acid receptors
|
341: Impairment, Learning and memory
|
|
|